Coppell Advisory Solutions LLC Has $116,000 Holdings in Centene Co. (NYSE:CNC)

Coppell Advisory Solutions LLC lifted its stake in shares of Centene Co. (NYSE:CNCFree Report) by 302.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,918 shares of the company’s stock after acquiring an additional 1,441 shares during the period. Coppell Advisory Solutions LLC’s holdings in Centene were worth $116,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Stratos Wealth Partners LTD. boosted its position in shares of Centene by 4.1% during the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company’s stock worth $248,000 after purchasing an additional 163 shares in the last quarter. Capital Advisors Ltd. LLC increased its holdings in shares of Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after acquiring an additional 177 shares in the last quarter. Private Trust Co. NA raised its position in shares of Centene by 23.7% during the fourth quarter. Private Trust Co. NA now owns 956 shares of the company’s stock worth $58,000 after purchasing an additional 183 shares during the period. Howard Capital Management Inc. lifted its holdings in shares of Centene by 5.4% in the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company’s stock worth $218,000 after purchasing an additional 184 shares in the last quarter. Finally, Intellectus Partners LLC increased its stake in Centene by 2.8% during the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company’s stock valued at $438,000 after purchasing an additional 200 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Performance

NYSE CNC opened at $57.74 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The company has a market capitalization of $28.64 billion, a PE ratio of 9.25, a price-to-earnings-growth ratio of 0.80 and a beta of 0.53. Centene Co. has a 52-week low of $55.03 and a 52-week high of $80.59. The company has a 50-day simple moving average of $60.10 and a 200 day simple moving average of $60.97.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $0.70. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company had revenue of $46.62 billion for the quarter, compared to analysts’ expectations of $43.16 billion. During the same quarter in the previous year, the firm posted $2.26 EPS. On average, research analysts predict that Centene Co. will post 6.86 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CNC shares. Guggenheim began coverage on shares of Centene in a report on Wednesday, April 9th. They set a “neutral” rating for the company. StockNews.com raised Centene from a “buy” rating to a “strong-buy” rating in a report on Friday, April 11th. Argus lowered Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Wells Fargo & Company decreased their price target on Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of Centene from an “underperform” rating to a “hold” rating and lifted their price objective for the stock from $53.00 to $64.00 in a report on Tuesday, April 8th. Seven analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and a consensus target price of $80.69.

Read Our Latest Analysis on Centene

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.